Human histocompatibility antigens and survival in acute myelocytic leukemia

M. Markman, H. G. Braine, W. B. Bias, Judith Karp

Research output: Contribution to journalArticle

Abstract

Several previous reports have suggested an association between human histocompatibility antigens (HLA) and survival in acute myelocytic leukemia (AML). The authors have retrospectively analyzed the records of 104 consecutive newly diagnosed patients with AML treated on the Leukemia Service of the Johns Hopkins Oncology Center from March 1978 through May 1982 who had HLA typing performed to further evaluate this point. The authors have been unable to demonstrate a statistically significant association of HLA phenotype with the ability to achieve a complete response (CR), length of CR, survival of the total group of treated patients, or survival of only those patients achieving a CR (P

Original languageEnglish (US)
Pages (from-to)1515-1517
Number of pages3
JournalCancer
Volume53
Issue number7
StatePublished - 1984

Fingerprint

Histocompatibility Antigens
Acute Myeloid Leukemia
Survival
Leukemia
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Markman, M., Braine, H. G., Bias, W. B., & Karp, J. (1984). Human histocompatibility antigens and survival in acute myelocytic leukemia. Cancer, 53(7), 1515-1517.

Human histocompatibility antigens and survival in acute myelocytic leukemia. / Markman, M.; Braine, H. G.; Bias, W. B.; Karp, Judith.

In: Cancer, Vol. 53, No. 7, 1984, p. 1515-1517.

Research output: Contribution to journalArticle

Markman, M, Braine, HG, Bias, WB & Karp, J 1984, 'Human histocompatibility antigens and survival in acute myelocytic leukemia', Cancer, vol. 53, no. 7, pp. 1515-1517.
Markman, M. ; Braine, H. G. ; Bias, W. B. ; Karp, Judith. / Human histocompatibility antigens and survival in acute myelocytic leukemia. In: Cancer. 1984 ; Vol. 53, No. 7. pp. 1515-1517.
@article{206bacb496da407ea81953726ee10177,
title = "Human histocompatibility antigens and survival in acute myelocytic leukemia",
abstract = "Several previous reports have suggested an association between human histocompatibility antigens (HLA) and survival in acute myelocytic leukemia (AML). The authors have retrospectively analyzed the records of 104 consecutive newly diagnosed patients with AML treated on the Leukemia Service of the Johns Hopkins Oncology Center from March 1978 through May 1982 who had HLA typing performed to further evaluate this point. The authors have been unable to demonstrate a statistically significant association of HLA phenotype with the ability to achieve a complete response (CR), length of CR, survival of the total group of treated patients, or survival of only those patients achieving a CR (P",
author = "M. Markman and Braine, {H. G.} and Bias, {W. B.} and Judith Karp",
year = "1984",
language = "English (US)",
volume = "53",
pages = "1515--1517",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Human histocompatibility antigens and survival in acute myelocytic leukemia

AU - Markman, M.

AU - Braine, H. G.

AU - Bias, W. B.

AU - Karp, Judith

PY - 1984

Y1 - 1984

N2 - Several previous reports have suggested an association between human histocompatibility antigens (HLA) and survival in acute myelocytic leukemia (AML). The authors have retrospectively analyzed the records of 104 consecutive newly diagnosed patients with AML treated on the Leukemia Service of the Johns Hopkins Oncology Center from March 1978 through May 1982 who had HLA typing performed to further evaluate this point. The authors have been unable to demonstrate a statistically significant association of HLA phenotype with the ability to achieve a complete response (CR), length of CR, survival of the total group of treated patients, or survival of only those patients achieving a CR (P

AB - Several previous reports have suggested an association between human histocompatibility antigens (HLA) and survival in acute myelocytic leukemia (AML). The authors have retrospectively analyzed the records of 104 consecutive newly diagnosed patients with AML treated on the Leukemia Service of the Johns Hopkins Oncology Center from March 1978 through May 1982 who had HLA typing performed to further evaluate this point. The authors have been unable to demonstrate a statistically significant association of HLA phenotype with the ability to achieve a complete response (CR), length of CR, survival of the total group of treated patients, or survival of only those patients achieving a CR (P

UR - http://www.scopus.com/inward/record.url?scp=0021331377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021331377&partnerID=8YFLogxK

M3 - Article

C2 - 6582993

AN - SCOPUS:0021331377

VL - 53

SP - 1515

EP - 1517

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -